What does CUSIP 630104AB3 represent in this 13F holders report?

CUSIP 630104AB3 is the security identifier for 630104AB3 - NANTHEALTH INC - NOTE 5.500%12/1 used to aggregate holder disclosures.

How many institutions held 630104AB3 - NANTHEALTH INC - NOTE 5.500%12/1 in Q4 2021?

No institutional holders were reported for 630104AB3 - NANTHEALTH INC - NOTE 5.500%12/1 in Q4 2021; review adjacent reporting periods for trend context.

NANTHEALTH INC - NOTE 5.500%12/1

CUSIP: 630104AB3

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Debt / NOTE 5.500%12/1
Total 13F principal: $0
Principal change: -$4,500,000
Total reported market value: $0
Number of holders: 0
Value change: -$4,450,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 630104AB3?
CUSIP 630104AB3 identifies 630104AB3 - NANTHEALTH INC - NOTE 5.500%12/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2021

Recent filing periods for CUSIP 630104AB3:

Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020

NANTHEALTH INC - NOTE 5.500%12/1

Q4 2021 13F Holders as of 31 Dec 2021

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of NANTHEALTH INC - NOTE 5.500%12/1 as of Q4 2021.